NCT03389399View on ClinicalTrials.gov

Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Non-Small Cell Lung Cancer
Trial Locations (5)

15232

University of Pittsburgh Cancer Institute, Pittsburgh

37232

Vanderbilt-Ingram Cancer Center, Nashville

75390

UT Southwestern Harold C Simmons Comprehensive Cancer Center, Dallas

80045

University of Colorado Denver, Aurora

M5G2C1

Princess Margaret Cancer Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

collaborator

Criterium, Inc.

INDUSTRY

lead

University of Colorado, Denver

OTHER